Type1 Diabetes
22
2
3
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
25%
4 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (22)
CGM Academy for Youth With Type 1 Diabetes
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
Evaluation of an Anti-inflammatory Diet in Autoimmune and Metabolic Diseases
Safe Use of New Technologies in Diabetes in Flight
Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age with Type 1 Diabetes
The Effect of Whey Protein Consumption on Hypoglycemia in Adults with Type 1 Diabetes During Fasting Ramadan.
Neural-net Artificial Pancreas (NAP)
Optimising Consultation Summaries to Promote Good Health
Canadian Bone Strength Development Study
Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet
Safety and Feasibility Study of the Eddii Mobile Application
Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)
Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
The Role of the Thymus in Type I Diabetes.
Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus